11β-13,14-dihydro-15-keto Prostaglandin F2α-d9
- CAS No.
- 2738376-88-8
- Chemical Name:
- 11β-13,14-dihydro-15-keto Prostaglandin F2α-d9
- Synonyms
- 11β-13,14-dihydro-15-keto Prostaglandin F2α-d9
- CBNumber:
- CB99739265
- Molecular Formula:
- C20H25D9O5
- Molecular Weight:
- 363.54
- MDL Number:
- MOL File:
- 2738376-88-8.mol
- MSDS File:
- SDS
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS02 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| NFPA 704 |
|
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 18787 | 11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 ≥99%deuteratedforms(d1-d9) | 2738376-88-8 | 50μg | $90 | 2026-04-30 | Buy |
| Cayman Chemical | 18787 | 11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 ≥99%deuteratedforms(d1-d9) | 2738376-88-8 | 100μg | $168 | 2026-04-30 | Buy |
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 Chemical Properties, Uses, Production
Description
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 (11β-13,14-dihydro-15-keto PGF2α-d9) is intended for use as an internal standard for the quantification of 11β-13,14-dihydro-15-keto PGF2α (Item No. 16540) by GC- or LC-MS. 11β-13,14-dihydro-15-keto PGF2α is a metabolite of prostaglandin D2 (PGD2; Item No. 12010) in the 15-hydroxy PGDH pathway.1,2 Infusion or inhalation of tritiated PGD2 in normal males results in the appearance of peak levels of both 11β-PGF2α, as the immediate product, and 11β-13,14-dihydro-15-keto PGF2α in the plasma within 10 minutes.1 Homogenates of human lung metabolize PGD2 first to 11β-PGF2α and then to 11β-15-keto-PGF2α in the presence of NAD+, but not 11β-13,14-dihydro-15-keto PGF2α.2 Guinea pig liver and kidney homogenates metabolize PGD2 to 11β-13,14-dihydro-15-keto PGF2α, via 11β-PGF2α, in the presence of NAD+ and NADP+.2WARNING This product is not for human or veterinary use.
References
[1] CLIVE ROBINSON Stephen T H Christopher C Hardy. The metabolism of prostaglandin D2 after inhalation or intravenous infusion in normal men[J]. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988, 963 2: Pages 151-161. DOI: 10.1016/0005-2760(88)90276-7
[2] C. ROBINSON. The metabolism of prostaglandin D2 evidence for the sequential conversion by NADPH and NAD+ dependent pathways[J]. Biochemical pharmacology, 1989, 38 19: Pages 3267-3271. DOI: 10.1016/0006-2952(89)90624-2
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 Preparation Products And Raw materials
Raw materials
Preparation Products
11β-13,14-dihydro-15-keto Prostaglandin F2α-d9 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11123 | 58 |
| CHINA ISOTOPE CO., LIMITED | 02151600108 13062666369 | info@isotopechem.com | China | 4721 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Supplier | Advantage |
|---|---|
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 58 |
| CHINA ISOTOPE CO., LIMITED | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 58 |
